Business Wire - June 05, 1998
...
Piran Sioshansi, "has application to various brachytherapy (irradiation within the body, as opposed to external beams) cancer treatment.
"In addition," he said, "evidence ...... This radioisotope is widely used for brachytherapy treatment of prostate cancer, so its characteristics are ...
See more references to Cancer treatment in this document
Business Wire - February 07, 2006
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c31990) has announced the addition of Bisphosphonates and Other Bone-Targeting Compounds in the Treatment of Cancer to their offering
Bisphosphonates ...
See more references to Cancer treatment in this document
Business Wire - February 16, 2006
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c33020) has announced the addition of Breast Cancer Therapeutics: How Innovation Is Shaping Future ......
The Breast Cancer Therapeutics Report seeks to explore and systematically analyze both drug targets and associated therapeutics in current clinical development relating to breast cancer. Four major classes of breast cancer ...
See more references to Cancer treatment in this document
Business Wire - January 16, 2007
... injectable suspension) (albumin-bound) for the treatment of metastatic breast cancer. The review period ...... A marketing authorization application is also currently under review with the European Medicines Agency (EMEA) for use of ABRAXANE in the treatment of breast cancer.
According to the National ...
See more references to Cancer treatment in this document
Business Wire - February 09, 2007
...
In this triple analysis report the author has analyzed three major and intertwined areas of cancer R&D, Apoptopic agents, Antibodies and Vaccines ......
There are today over 190 apoptopic drugs in active development for the treatment of more than 40 different cancer indications. ...
See more references to Cancer treatment in this document
Business Wire - April 13, 2006
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c35509) has announced the addition of Non-Antibody Based Cancer Vaccines: Drug Pipeline Update 2006 to their ...... Vaccines are being developed for over 30 different cancer indications and the number of vaccine targets ...
See more references to Cancer treatment in this document
Business Wire - April 13, 2007
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c54057) has announced the addition of "Breast Cancer Drug Pipeline Update 2007" to their offering.
......) and one monoclonal antibody (Herceptin) as a treatment option for breast cancer. AstraZeneca reported ...
See more references to Cancer treatment in this document
Business Wire - January 18, 2007
... This product launch came only a few months after the successful introduction of another cancer-treatment ingredient, Paclitaxel, from ......
As for Paclitaxel, a widely used anti-cancer drug substance in the US market, ScinoPharm was ...
See more references to Cancer treatment in this document
Business Wire - April 19, 2007
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c54382) has announced the addition of New Cancer Drug Tracker: AP23573 to their offering.
Long ......
The high cost of new cancer therapies has made them targets for critical ...
See more references to Cancer treatment in this document
